Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-11
2007-09-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C540S456000
Reexamination Certificate
active
11103799
ABSTRACT:
A method for the regiospecific synthesis of rapamycin 42-ester derivatives is described. The method involves lipase-catalyzed acetylation of 42-hydroxy of rapamycin with an acyl donor such as a vinyl ester, an isopropenyl ester or an anhydride in a suitable organic solvent.
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4316885 (1982-02-01), Rakhit
patent: 4650803 (1987-03-01), Stella et al.
patent: 5100883 (1992-03-01), Schichser
patent: 5118677 (1992-06-01), Caufield
patent: 5118678 (1992-06-01), Kao et al.
patent: 5233036 (1993-08-01), Hughes
patent: 5260300 (1993-11-01), Hu
patent: 5362718 (1994-11-01), Skotnicki et al.
patent: 6277983 (2001-08-01), Shaw et al.
patent: 6432973 (2002-08-01), Zhu et al.
patent: 2005/0033046 (2005-02-01), Chew et al.
patent: 2005/0049271 (2005-03-01), Benjamin et al.
patent: 2005/0152983 (2005-07-01), Ashraf et al.
patent: 0 464 895 (1992-01-01), None
patent: 0781 776 (2003-03-01), None
patent: WO92/05179 (1992-04-01), None
patent: WO95/28406 (1995-10-01), None
patent: WO 01/23395 (2001-04-01), None
patent: WO 02/24706 (2002-03-01), None
patent: WO 04/011000 (2004-02-01), None
patent: WO 05/016935 (2005-02-01), None
M. Adamczyk, et al., Lipase Mediated Hydrolysis of Rapamycin 42-Hemisuccinate Benzyl and Methyl Esters, Tetrahedron Letters, Feb. 14, 1994, pp. 1019-1022, Vo. 35, No. 7, Elsevier Science Ltd., Great Britain.
McGraw-Hill Dictionary of Scientific and Technical Terms, 3rded. (1984), p. 996.
Cai Ping
Gu Jianxin
Ruppen Mark E.
Howson & Howson LLP
Kifle Bruck
Milowsky Arnold S.
Wyeth
LandOfFree
Regiospecific synthesis of rapamycin 42-ester derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regiospecific synthesis of rapamycin 42-ester derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regiospecific synthesis of rapamycin 42-ester derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3785107